Steven Myint

Steven Myint

Vorstandsvorsitzender bei
Moewin Associates Ltd.
68 Jahre
Consumer Services
Health Technology
Health Services

Profil

Steven Myint currently works at Inex Innovations Exchange Pte Ltd, as Chairman, GlaxoSmithKline Oy, as Global Medical Director, Moewin Associates Ltd., as Managing Director, Aplagon Oy, as Non-Executive Director, and Vickers Vantage Corp.
II, as Independent Director.
Dr. Myint also formerly worked at Plexpress Oy, as Chairman, OnMedica Group Ltd., as Executive Chairman, GreenSignal Bio Pharma Ltd., as Executive Chairman, CARE International UK, as Director, Vickers Vantage Corp.
I, as Independent Director, BTG International Ltd., as Chief Medical Officer, SVP-Research & Development from 2007 to 2009, the University of Leicester, as Professor-Microbiology & Immunology, and the University of Surrey, as Professor, Dean-Medicine & Health.
Dr. Myint received his doctorate degree from the University of London and doctorate degree from Julius-Maximilians-Universität Würzburg.

Aktive Positionen von Steven Myint

UnternehmenPositionBeginn
Technik-/Wissenschafts-/F&E-Leiter -
Moewin Associates Ltd.
Vorstandsvorsitzender -
Direktor/Vorstandsmitglied -
Vorsitzender -

Ehemalige bekannte Positionen von Steven Myint

UnternehmenPositionEnde
Technik-/Wissenschafts-/F&E-Leiter 01.01.2009
Vorsitzender -
Vorsitzender -
Direktor/Vorstandsmitglied -
VICS VANT Direktor/Vorstandsmitglied -
Sehen Sie sich die Erfahrung von Steven Myint im Detail an

Ausbildung von Steven Myint

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

16

Beziehungen ersten Grades

14

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen14

Commercial Services

Technology Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Services

Consumer Services

Moewin Associates Ltd.

Finance

Health Technology

Health Services

Finance

  1. Börse
  2. Insiders
  3. Steven Myint